DE69532970D1 - Sprühgetrocknetes erythropoietin - Google Patents

Sprühgetrocknetes erythropoietin

Info

Publication number
DE69532970D1
DE69532970D1 DE69532970T DE69532970T DE69532970D1 DE 69532970 D1 DE69532970 D1 DE 69532970D1 DE 69532970 T DE69532970 T DE 69532970T DE 69532970 T DE69532970 T DE 69532970T DE 69532970 D1 DE69532970 D1 DE 69532970D1
Authority
DE
Germany
Prior art keywords
sprühgetrocknetes
erythropoietin
rhepo
provides
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69532970T
Other languages
English (en)
Other versions
DE69532970T3 (de
DE69532970T2 (de
Inventor
B Mehta
C Corbo
Khurshid Iqbal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23407689&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69532970(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of DE69532970D1 publication Critical patent/DE69532970D1/de
Application granted granted Critical
Publication of DE69532970T2 publication Critical patent/DE69532970T2/de
Publication of DE69532970T3 publication Critical patent/DE69532970T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
DE69532970T 1994-12-16 1995-12-15 Sprühgetrocknetes erythropoietin Expired - Lifetime DE69532970T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35794794A 1994-12-16 1994-12-16
US357947 1994-12-16
EP95943452A EP0805822B2 (de) 1994-12-16 1995-12-15 Sprühgetrocknetes erythropoietin
PCT/US1995/016416 WO1996018647A1 (en) 1994-12-16 1995-12-15 Spray dried erythropoietin

Publications (3)

Publication Number Publication Date
DE69532970D1 true DE69532970D1 (en) 2004-06-03
DE69532970T2 DE69532970T2 (de) 2005-06-09
DE69532970T3 DE69532970T3 (de) 2012-02-09

Family

ID=23407689

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69532970T Expired - Lifetime DE69532970T3 (de) 1994-12-16 1995-12-15 Sprühgetrocknetes erythropoietin

Country Status (19)

Country Link
US (2) US6001800A (de)
EP (1) EP0805822B2 (de)
JP (1) JP4039686B2 (de)
CN (1) CN1117762C (de)
AT (1) ATE265468T1 (de)
AU (1) AU697287B2 (de)
CA (1) CA2207615C (de)
DE (1) DE69532970T3 (de)
DK (1) DK0805822T4 (de)
ES (1) ES2219672T5 (de)
FI (1) FI119723B (de)
HU (1) HU222370B1 (de)
IL (1) IL116085A (de)
NO (1) NO319895B1 (de)
NZ (1) NZ298981A (de)
PT (1) PT805822E (de)
TW (1) TW425287B (de)
WO (1) WO1996018647A1 (de)
ZA (1) ZA9510708B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
US6151332A (en) 1997-06-20 2000-11-21 Tantivy Communications, Inc. Protocol conversion and bandwidth reduction technique providing multiple nB+D ISDN basic rate interface links over a wireless code division multiple access communication system
US6081536A (en) 1997-06-20 2000-06-27 Tantivy Communications, Inc. Dynamic bandwidth allocation to transmit a wireless protocol across a code division multiple access (CDMA) radio link
US6542481B2 (en) 1998-06-01 2003-04-01 Tantivy Communications, Inc. Dynamic bandwidth allocation for multiple access communication using session queues
EP0913177A1 (de) * 1997-11-03 1999-05-06 Roche Diagnostics GmbH Verfahren zur Herstellung trockener, amorpher Produkte enthaltend biologisch aktive Materialien mittels Konvektionstrocknung, insbesondere Sprühtrocknung
US7496072B2 (en) 1997-12-17 2009-02-24 Interdigital Technology Corporation System and method for controlling signal strength over a reverse link of a CDMA wireless communication system
US9525923B2 (en) 1997-12-17 2016-12-20 Intel Corporation Multi-detection of heartbeat to reduce error probability
US6222832B1 (en) 1998-06-01 2001-04-24 Tantivy Communications, Inc. Fast Acquisition of traffic channels for a highly variable data rate reverse link of a CDMA wireless communication system
US7936728B2 (en) 1997-12-17 2011-05-03 Tantivy Communications, Inc. System and method for maintaining timing of synchronization messages over a reverse link of a CDMA wireless communication system
US7394791B2 (en) 1997-12-17 2008-07-01 Interdigital Technology Corporation Multi-detection of heartbeat to reduce error probability
US8134980B2 (en) 1998-06-01 2012-03-13 Ipr Licensing, Inc. Transmittal of heartbeat signal at a lower level than heartbeat request
US7773566B2 (en) 1998-06-01 2010-08-10 Tantivy Communications, Inc. System and method for maintaining timing of synchronization messages over a reverse link of a CDMA wireless communication system
US6526034B1 (en) 1999-09-21 2003-02-25 Tantivy Communications, Inc. Dual mode subscriber unit for short range, high rate and long range, lower rate data communications
WO2001058044A2 (en) 2000-02-07 2001-08-09 Tantivy Communications, Inc. Minimal maintenance link to support synchronization
US8155096B1 (en) 2000-12-01 2012-04-10 Ipr Licensing Inc. Antenna control system and method
US6954448B2 (en) 2001-02-01 2005-10-11 Ipr Licensing, Inc. Alternate channel for carrying selected message types
US7551663B1 (en) 2001-02-01 2009-06-23 Ipr Licensing, Inc. Use of correlation combination to achieve channel detection
EP1471871B1 (de) 2001-02-02 2007-05-02 Ortho-McNeil Pharmaceutical, Inc. Behandlung von neurologischen funktionsstörungen mit fructopyranosesulfamaten und erythropoetin
ES2626289T3 (es) 2001-06-13 2017-07-24 Intel Corporation Método y aparatos para la transmisión de señal de latido a un nivel más bajo que la solicitud de latido
ATE466085T1 (de) * 2002-09-09 2010-05-15 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
EP1578394A4 (de) * 2002-12-31 2011-02-23 Nektar Therapeutics Antikörperhaltige partikel und zusammensetzungen
EP1683812B1 (de) 2003-11-14 2014-11-12 Chugai Seiyaku Kabushiki Kaisha Mikroteilchen aus vernetztem polysaccharid und deren herstellungsverfahren
EP1836314B1 (de) 2004-12-22 2012-01-25 Ambrx, Inc. Modifiziertes menschliches wachstumshormon
JP5425398B2 (ja) 2004-12-22 2014-02-26 アンブレツクス・インコーポレイテツド 非天然アミノ酸及びポリペプチドを含む組成物、非天然アミノ酸及びポリペプチドに関連する方法並び非天然アミノ酸及びポリペプチドその使用
US20090018029A1 (en) 2005-11-16 2009-01-15 Ambrx, Inc. Methods and Compositions Comprising Non-Natural Amino Acids
JP5840345B2 (ja) 2006-09-08 2016-01-06 アンブルックス, インコーポレイテッドAmbrx, Inc. 修飾ヒト血漿ポリペプチドまたは修飾ヒトＦｃ足場タンパク質ならびにこれらの利用
EP2120998B1 (de) 2006-11-28 2013-08-07 HanAll Biopharma Co., Ltd. Modifizierte erythropoetin-polypeptide und ihre verwendungen zur behandlung
KR101476472B1 (ko) 2007-03-30 2015-01-05 암브룩스, 인코포레이티드 변형된 ｆｇｆ-21 폴리펩티드 및 그 용도
JP2010525821A (ja) 2007-05-02 2010-07-29 アンブルックス，インコーポレイテッド 修飾ＩＦＮβポリペプチドおよびこれらの使用
NZ621174A (en) * 2008-01-15 2015-09-25 Abbvie Deutschland Powdered protein compositions and methods of making same
EP3225248B1 (de) 2008-07-23 2023-06-07 Ambrx, Inc. Modifizierte bovine g-csf-polypeptide und ihre verwendung
PT104350A (pt) 2009-01-23 2010-07-23 Hovione Farmaci Ncia S A Processo de isolamento de tigeciclina
NZ600363A (en) 2009-12-21 2014-07-25 Ambrx Inc Modified porcine somatotropin polypeptides and their uses
EP2805964A1 (de) 2009-12-21 2014-11-26 Ambrx, Inc. Modifizierte Rinder-Somatotropinpolypeptide und deren Verwendungen
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
AU2012204462A1 (en) 2011-01-05 2013-07-11 Hospira, Inc. Spray drying vancomycin
WO2013126552A1 (en) 2012-02-21 2013-08-29 Auburn University Buprenorphine nanoparticle composition and methods thereof
CN104043104B (zh) 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法
UY36370A (es) 2014-10-24 2016-04-29 Bristol Myers Squibb Company Una Corporación Del Estado De Delaware Polipéptidos fgf-21 modificados y sus usos
CN104984323B (zh) * 2015-06-12 2018-05-01 北京四环生物制药有限公司 注射用重组人促红素冻干粉针剂
CN105311624A (zh) * 2015-11-23 2016-02-10 哈药集团生物工程有限公司 一种含有重组人促红素的药物组合物
JP7441826B2 (ja) 2018-09-11 2024-03-01 アンブルックス，インコーポレイテッド インターロイキン－２ポリペプチド抱合物およびその使用
AU2019361206A1 (en) 2018-10-19 2021-06-03 Ambrx, Inc. Interleukin-10 polypeptide conjugates, dimers thereof, and their uses
JP2022520792A (ja) 2019-02-12 2022-04-01 アンブルックス，インコーポレイテッド 抗体－ｔｌｒアゴニストコンジュゲートを含有する組成物、その方法、及び使用
CA3174114A1 (en) 2020-03-11 2021-09-16 Ambrx, Inc. Interleukin-2 polypeptide conjugates and methods of use thereof
JP2023538071A (ja) 2020-08-20 2023-09-06 アンブルックス，インコーポレイテッド 抗体－ｔｌｒアゴニストコンジュゲート、その方法及び使用
CA3213805A1 (en) 2021-04-03 2022-10-06 Feng Tian Anti-her2 antibody-drug conjugates and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57149228A (en) * 1981-03-11 1982-09-14 Ajinomoto Co Inc Novel erythropoietin and its preparation
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
GB9001987D0 (en) * 1990-01-29 1990-03-28 Janssen Pharmaceutica Nv Improved cyclodextrin based erythropietin formulation
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin

Also Published As

Publication number Publication date
IL116085A0 (en) 1996-01-31
EP0805822B1 (de) 2004-04-28
CA2207615A1 (en) 1996-06-20
AU697287B2 (en) 1998-10-01
ES2219672T5 (es) 2011-09-26
ZA9510708B (en) 1997-06-17
CA2207615C (en) 2010-12-14
MX9704504A (es) 1998-06-30
ES2219672T3 (es) 2004-12-01
DK0805822T3 (da) 2004-08-16
NO972725L (no) 1997-08-06
NZ298981A (en) 1999-11-29
ATE265468T1 (de) 2004-05-15
CN1117762C (zh) 2003-08-13
EP0805822A1 (de) 1997-11-12
NO319895B1 (no) 2005-09-26
HU222370B1 (hu) 2003-06-28
DK0805822T4 (da) 2011-07-11
FI972557A (fi) 1997-08-14
IL116085A (en) 1999-12-31
US6001800A (en) 1999-12-14
AU4471396A (en) 1996-07-03
HUT77811A (hu) 1998-08-28
DE69532970T3 (de) 2012-02-09
TW425287B (en) 2001-03-11
EP0805822B2 (de) 2011-06-15
FI119723B (fi) 2009-02-27
WO1996018647A1 (en) 1996-06-20
JPH10511087A (ja) 1998-10-27
PT805822E (pt) 2004-08-31
FI972557A0 (fi) 1997-06-16
US6235710B1 (en) 2001-05-22
DE69532970T2 (de) 2005-06-09
CN1175261A (zh) 1998-03-04
JP4039686B2 (ja) 2008-01-30
NO972725D0 (no) 1997-06-13

Similar Documents

Publication Publication Date Title
DE69532970D1 (en) Sprühgetrocknetes erythropoietin
EP0702040A3 (de)
HK1010196A1 (en) Novel 2,3-dioxo-1,2,3,4-tetrahdro-quinoyxalinyl derivatives.
HUP0002105A3 (en) Method for preparing 1,1,1,3,3-pentachlorobutane
AU1148099A (en) Powder varnish composition, method for producing and the use thereof
EP1023250A4 (de) Verfahren zur herstellung von 2,6-dialkylnaphthalin
ZA974084B (en) Novel α-glucuronidases, production hereof and their uses.
AU2316897A (en) Cyclic imido-1,3,5-triazine crosslinking agents
GB2289682B (en) Self-crosslinking composition,a product obtained from the composition,and method for manufacturing the product
MX9603516A (es) Derivados de oxima y su uso como pesticidas.
EP0653466A3 (de) Pulverlack.
HUP9802316A3 (en) Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
EP0653246A3 (de) Zerstäuber.
EP0694538A3 (de) 2-Benzyloxy-4-phenoxypyrimidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende herbizide Zusammensetzungen
HUT77004A (hu) Antiaritmiás szerekként felhasználható nitro-benzamidok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
AU7570798A (en) Ionic halomethyl-1,3,5-triazine photoinitiators
ZA978831B (en) Stable, one package coating compositions and process for coating.
EP0680790A3 (de) Pulverdüse.
ZA972302B (en) 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives.
AU1568895A (en) Process for preparing 2,6-dichloropyridine
AU4715196A (en) Desaminononapeptides, process for preparing the same and their use for preparing elcatonin
AU7035998A (en) New thiazoledinediones, method for the production thereof, and medicaments containing the same
ZA991215B (en) Process for the preparation of 1,3-disubstituted 2-nitroguanidines.
NO902138D0 (no) Fremgangsmaate for pulverbelegging.
AU5322198A (en) New phosphonates, process for preparing the same and medicaments

Legal Events

Date Code Title Description
8363 Opposition against the patent
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

R102 Epo decision maintaining patent in amended form now final

Ref document number: 805822

Country of ref document: EP

Effective date: 20110615